Cita APA

Luna, A., Boqué-Genovard, C., Giraldo, P., Ruiz Nuño, C., Cortes, M., Pérez-Lamas, L., & Xicoy, B. (2022). Real‑life analysis on safety and efcacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia.

Citación estilo Chicago

Luna, Alejandro, Concepción Boqué-Genovard, Pilar Giraldo, C. Ruiz Nuño, Montse Cortes, Lucía Pérez-Lamas, y Blanca Xicoy. Real‑life Analysis On Safety and Efcacy of Asciminib for Ponatinib Pretreated Patients With Chronic Myeloid Leukemia. 2022.

Cita MLA

Luna, Alejandro, et al. Real‑life Analysis On Safety and Efcacy of Asciminib for Ponatinib Pretreated Patients With Chronic Myeloid Leukemia. 2022.